Riverside Medical Center Performs First In-Patient Use of Biomaterial-Based HydroPICC® Dual Lumen Catheter
December 12, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to...
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022 08:45 ET
|
Palisade Bio, Inc.
Carlsbad, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc., (Nasdaq: PALI) a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
$6+ Billion Fetal Monitoring Market Size to Grow at a CAGR of 7.6% by 2028 | The Insight Partners
October 31, 2022 10:41 ET
|
The Insight Partners
New York, Oct. 31, 2022 (GLOBE NEWSWIRE) -- According to our latest market study on "Fetal Monitoring Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and Global...
Access Vascular Integrative Review Published in International Journal of Nursing and Healthcare Research Establishes Economic Impact of Biomaterial Catheters
October 31, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
Journal of Infusion Nursing Publishes Access Vascular Data Showing Significantly Reduced Complication Rates for HydroMID
September 19, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
New Access Vascular Retrospective Data Review Demonstrates Midline Catheters Composed of Advanced Biomaterials May Improve Dwell Times
July 12, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today shared initial findings from a retrospective review of patient records that demonstrates an increase in dwell...
NEW REPORT: Advanced Nuclear Technology Will Provide Critical Climate and Energy Benefits to the Future US Clean Energy System
July 06, 2022 07:00 ET
|
Breakthrough Institute
Berkeley, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Today, the Breakthrough Institute released a groundbreaking new report detailing how the deployment of advanced nuclear technology will provide...
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
May 10, 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough...
Access Vascular Receives FDA Clearance for HydroPICC® Biomaterial-Based Dual-Lumen Catheter
May 05, 2022 11:48 ET
|
Access Vascular
BILLERICA, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC®...
FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies
May 02, 2022 09:00 ET
|
Gb Sciences
LAS VEGAS, May 02, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, announces that FHI Clinical Inc. will...